91 related articles for article (PubMed ID: 23533248)
1. Cardiac hormones for the treatment of cancer.
Vesely DL
Endocr Relat Cancer; 2013 Jun; 20(3):R113-25. PubMed ID: 23533248
[TBL] [Abstract][Full Text] [Related]
2. Family of peptides synthesized in the human body have anticancer effects.
Vesely DL
Anticancer Res; 2014 Apr; 34(4):1459-66. PubMed ID: 24692673
[TBL] [Abstract][Full Text] [Related]
3. Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer.
Vesely DL
Anticancer Res; 2016 Nov; 36(11):5693-5700. PubMed ID: 27793890
[TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides' metabolic targets for treatment of cancer.
Vesely DL
J Investig Med; 2013 Jun; 61(5):816-22. PubMed ID: 23612148
[TBL] [Abstract][Full Text] [Related]
5. New anticancer agents: hormones made within the heart.
Vesely DL
Anticancer Res; 2012 Jul; 32(7):2515-21. PubMed ID: 22753708
[TBL] [Abstract][Full Text] [Related]
6. Central role of β-catenin in anticancer effects of cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
[TBL] [Abstract][Full Text] [Related]
7. Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.
Manimala NJ; Frost CD; Lane ML; Higuera M; Beg R; Vesely DL
Eur J Clin Invest; 2013 Nov; 43(11):1156-62. PubMed ID: 23992401
[TBL] [Abstract][Full Text] [Related]
8. Cardiac and renal hormones: anticancer effects in vitro and in vivo.
Vesely DL
J Investig Med; 2009 Jan; 57(1):22-8. PubMed ID: 19092678
[TBL] [Abstract][Full Text] [Related]
9. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
Eur J Clin Invest; 2010 Mar; 40(3):242-9. PubMed ID: 20415699
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.
Eichelbaum EJ; Sun Y; Alli AA; Gower WR; Vesely DL
Eur J Clin Invest; 2008 Aug; 38(8):562-70. PubMed ID: 18717826
[TBL] [Abstract][Full Text] [Related]
12. Metabolic targets of cardiac hormones' therapeutic anti-cancer effects.
Vesely DL
Curr Pharm Des; 2010; 16(9):1159-66. PubMed ID: 20030620
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
[TBL] [Abstract][Full Text] [Related]
14. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
[TBL] [Abstract][Full Text] [Related]
15. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor's activation of Ras is inhibited by four cardiac hormones.
Sun Y; Eichelbaum EJ; Lenz A; Wang H; Vesely DL
Eur J Clin Invest; 2010 May; 40(5):408-13. PubMed ID: 20353436
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic approach for cancer using four cardiovascular hormones.
Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
[TBL] [Abstract][Full Text] [Related]
18. Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.
Vesely BA; Eichelbaum EJ; Alli AA; Sun Y; Gower WR; Vesely DL
Eur J Clin Invest; 2006 Nov; 36(11):810-9. PubMed ID: 17032349
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways.
Vesely DL
Cancers (Basel); 2011 Mar; 3(1):1182-94. PubMed ID: 24212659
[TBL] [Abstract][Full Text] [Related]
20. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]